Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody

Sara Insausti, Ander Ramos-Caballero, Brian Wiley, Saul González-Resines, Johana Torralba, Anne Elizaga-Lara, Christine Shamblin, Akio Ojida, Jose M. M. Caaveiro, Michael B. Zwick, Edurne Rujas, Carmen Domene, José L. Nieva

Research output: Contribution to journalArticlepeer-review

1 Citation (SciVal)

Abstract

Establishment of interactions with the envelope lipids is a cardinal feature of broadly neutralizing antibodies (bnAbs) that recognize the Env membrane-proximal external region (MPER) of HIV. The lipid envelope constitutes a relevant component of the full “quinary” MPER epitope, and thus antibodies may be optimized through engineering their capacity to interact with lipids. However, the role of the chemically complex lipid nanoenvironment in the mechanism of MPER molecular recognition and viral neutralization remains poorly understood. To approach this issue, we computationally and experimentally investigated lipid interactions of broadly neutralizing antibody 10E8 and optimized versions engineered to enhance their epitope and membrane affinity by grafting bulky aromatic compounds. Our data revealed a correlation between neutralization potency and the establishment of favorable interactions with small headgroup lipids cholesterol and phosphatidylethanolamine, evolving after specific engagement with MPER. Molecular dynamics simulations of chemically modified Fabs in complex with an MPER-Transmembrane Domain helix supported the generation of a nanoenvironment causing localized deformation of the thick, rigid viral membrane and identified sphingomyelin preferentially occupying a phospholipid-binding site of 10E8. Together, these interactions appear to facilitate insertion of the Fabs through their engagement with the MPER epitope. These findings implicate individual lipid molecules in the neutralization function of MPER bnAbs, validate targeted chemical modification as a method to optimize MPER antibodies, and suggest pathways for MPER peptide-liposome vaccine development.
Original languageEnglish
Pages (from-to)59934-59948
Number of pages15
JournalACS applied materials & interfaces
Volume16
Issue number44
Early online date24 Oct 2024
DOIs
Publication statusPublished - 6 Nov 2024

Funding

This study was supported by Grants PID2021-126014OB-I00 and PID2021-122212OA-I00 funded by the MCIN/AEI/10.13039/501100011033/FEDER,UE, and by the Grant IT1449-22 funded by the Basque Government. S.I. acknowledges a research contract from the University of the Basque Country (DOCREC21/20). A.R.-C. acknowledges a predoctoral contract from the Basque Government. C.D. acknowledges PRACE for awarding access to computational resources in CSCS, the Swiss National Supercomputing Service, in two of their Project Access Calls. This project also made use of computing time on UK Tier 2 JADE and Bede, granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim ( http://hecbiosim.ac.uk ), supported by EPSRC (grant no. EP/R029407/1). B.W. was supported by U.K. Research and Innovation (UKRI), grant reference number EP/S023437/1. M.Z. acknowledges funding support from the US National Institutes of Health R01-AI143563. E.R. acknowledges funding by the ERC (grant H2020-MSCA-COFUND-2020-101034228-WOLFRAM2). This work was also supported by the Platform Project for Supporting Drug Discovery and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED (24ama121031j0003) to A.O. and J.M.M.C. Technical assistance by Miguel Garcia-Porras is greatly acknowledged. The authors also wish to thank Pablo Carravilla for helpful discussions on the content of the manuscript and for his assistance in the production of A. For the purpose of open access, B.W. has applied a Creative Commons Attribution (CC-BY) license to any Author Accepted Manuscript version arising.

FundersFunder number
Eusko Jaurlaritza
Japan Agency for Medical Research and Development24ama121031j0003
Japan Agency for Medical Research and Development
European Research CouncilH2020-MSCA-COFUND-2020-101034228-WOLFRAM2
European Research Council
Engineering and Physical Sciences Research CouncilEP/R029407/1
Engineering and Physical Sciences Research Council
National Institutes of HealthR01-AI143563
National Institutes of Health
UK Research and InnovationEP/S023437/1
UK Research and Innovation
University of the Basque CountryDOCREC21/20
University of the Basque Country

Keywords

  • HIV-1 antibody
  • antibody engineering
  • antibody-membrane interaction
  • lipid nanoenvironment
  • membrane deformation
  • metadynamics
  • molecular dynamics simulations
  • site-selective chemical modification

ASJC Scopus subject areas

  • General Materials Science

Fingerprint

Dive into the research topics of 'Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody'. Together they form a unique fingerprint.

Cite this